TriNessa Articles
Barr's profits up 24% to $76M
15 May 2006
Barr 2nd-qtr turnover rockets 79%
16 February 2004
Barr introduces generic Tri-Cyclen
5 January 2004
Watson launches TriNessa oral contraceptive
5 January 2004
Showing 1-4 of 4 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
